Abstract
Background
This study examines hospital charges and length of stay (LOS) associated with septicemia during hospitalization for leukemia treatment among children aged ≤18 years.
Methods
Nationwide Inpatient Sample (year 2008) was used. All hospitalizations (regardless of their discharge status following hospitalization) among children aged ≤18 years with a primary diagnosis of leukemia were selected. Leukemia was identified using ICD-9-CM codes in the primary diagnosis field. The presence of septicemia during hospitalization was identified using ICD-9-CM codes in the secondary diagnosis fi eld. Multivariable linear regression analyses were made to examine the effect of septicemia on hospitalization charges and LOS.
Results
Totally 6220 hospitalizations were attributed to leukemia treatment. Among these, 787 had septicemia. The mean hospitalization charge for those with septicemia was $279 137 and for those without septicemia was $113 530. The average LOS for those with septicemia was 33.18 days while the LOS for those without septicemia was 13.79 days. Septicemia was associated with increased hospitalization charges and a prolonged duration of stay in hospital after adjustments for confounders (P<0.0001).
Conclusions
Septicemia is associated with adverse outcomes among children hospitalized for leukemia treatment.
Similar content being viewed by others
References
US Mortality data (2005). National Center for Health Statistics, Centers for Disease Control and Prevention. 2008.
Surveillance, Epidemiology, and End Results Program, 1975–2004. Division of Cancer Control and Population Sciences, National Cancer Institute. 2007.
American Cancer Society: Cancer Statistics 2008.
Arceci RJ. Progress and controversies in the treatment of pediatric acute myelogenous leukemia. Curr Opin Hematol 2002;9:353–360.
Ben Abraham R, Toren A, Ono N, Weinbroum AA, Vardi A, Barzilay Z, et al. Predictors of outcome in the pediatric intensive care units of children with malignancies. J Pediatr Hematol Oncol 2002;24:23–26.
Fiser RT, West NK, Bush AJ, Sillos EM, Schmidt JE, Tamburro RF. Outcome of severe sepsis in pediatric oncology patients. Pediatr Crit Care Med 2005;6:531–536.
Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukaemia—current status and future perspectives. Lancet Oncol 2001;2:597–607.
Tamburro R. Pediatric cancer patients in clinical trials of sepsis: factors that predispose to sepsis and stratify outcome. Pediatr Crit Care Med 2005;6(3 Suppl):S87–91.
Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003;167:695–701.
HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP), 2008. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. http://www.hcup-us.ahrq.gov/nisoverview.jsp (accessed November 20, 2010).
Nationwide Inpatient Sample (NIS) — Description of Data Elements. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. http://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp (accessed November 20, 2010).
Nationwide Inpatient Sample (NIS) — HCUP Coding Practices. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. http://www.hcupus.ahrq.gov/db/coding.jsp (accessed November 20, 2010).
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27.
Bonig H, Schneider DT, Sprock I, Lemburg P, Gobel U, Nurnberger W. ’sepsis’ and multi-organ failure: predictors of poor outcome after hematopoietic stem cell transplantation in children. Bone Marrow Transplant 2000;25 Suppl 2:S32–34.
Hallahan AR, Shaw PJ, Rowell G, O’Connell A, Schell D, Gillis J. Improved outcomes of children with malignancy admitted to a pediatric intensive care unit. Crit Care Med 2000;28:3718–3721.
van Veen A, Karstens A, van der Hoek AC, Tibboel D, Hahlen K, van der Voort E. The prognosis of oncologic patients in the pediatric intensive care unit. Intensive Care Med 1996;22:237–241.
Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, et al. Infl uence of systemic infl ammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003;168:77–84.
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303–1310.
Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001;29(7 Suppl):S109–116.
Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 2004;8:R291–298.
Chanock S. Evolving risk factors for infectious complications of cancer therapy. Hematol Oncol Clin North Am 1993;7:771–793.
Allegretta GJ, Weisman SJ, Altman A. Oncologic emergencies II. Hematologic and infectious complications of cancer and cancer treatment. Pediatr Clin North Am 2003;32:613–624.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allareddy, V., Rampa, S. & Allareddy, V. Hospital charges and length of stay associated with septicemia among children hospitalized for leukemia treatment in the United States. World J Pediatr 8, 222–228 (2012). https://doi.org/10.1007/s12519-012-0361-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-012-0361-5